Alere Refuses Abbott Bid To Back Out Of $5.8B Merger
Alere Inc. said Thursday that its board of directors rejected a request by Abbott Laboratories, which expressed concerns about the diagnostic services provider's pending foreign bribery probe and delays with its...To view the full article, register now.
Already a subscriber? Click here to view full article